In this episode of Targeted Talks, Edwin Choy, MD, PhD, discussed the FDA approval of afamitresgene autoleucel for the treatment of patients with advanced synovial sarcoma.
Edwin Choy, MD
Edwin Choy, MD, is the director, Sarcoma Oncology Program at Massachusetts General Hospital and associate professor of medicine, Harvard Medical School
Articles by Edwin Choy, MD
Edwin Choy, MD, PhD, discusses the mechanism of action of afamitresgene autoleucel and the recent accelerated approval from the FDA for patients with advanced synovial sarcoma.
Edwin Choy, MD, provides key recommendations for community oncologists treating patients with gastrointestinal stromal tumor.
Edwin Choy, MD, discusses adjuvant treatments for patients with gastrointestinal stromal tumors.